Early diagnostics of prostate cancer based on a comprehensive analysis of risk factors

Author:

Lazarev Alexander F.ORCID,Petrova Valentina D.ORCID,Lazarev Sergey A.ORCID,Repkina Tatiana V.ORCID,Terekhova Svetlana A.ORCID,Obеremok Pavel A.ORCID,Osipov Ilya S.ORCID,Nikolaeva Maria G.ORCID,Ganov Dmitriy I.ORCID

Abstract

BACKGROUND: There is a trend of increasing incidence and mortality from prostate cancer. Existing methods for early diagnosis and screening of prostate cancer did not demonstrate enough efficiency. AIM: To improve the quality and efficiency of diagnostic measures for prostate cancer through a personalized approach to patients based on an analysis of a set of risk factors. MATERIALS AND METHODS: The methodology was developed using the data from the population-based Cancer Registry of the Altai Territory, created at the Altai Regional Oncology Center in Barnaul, Russia. At the moment the Cancer Registry included information on 308 550 patients with malignant neoplasms, including 15 167 males with prostate cancer. On the basis of the method of prostate cancer risk assessment proposed by Lazarev AF an automated program for early diagnosis of prostate cancer has been developed. Testing of this technique included assessment of 532 patients (aged between 23 and 82). RESULTS: 128 patients were determined to belong to the high risk pre-cancer group. A high-risk precancer registry was created, which included the patients having individual risk of developing prostate cancer either increased or high or absolute. Upon a set of in-depth examinations, 7 of 128 patients (9.3%) were diagnosed with prostate cancer, all at early stages (I or II). Thus, the incidence of prostate cancer among the patients from the high risk pre-cancer registry was significantly higher than the average observed during prophylactic examinations (0.01%). CONCLUSION: The automated program for early diagnosis of prostate cancer could be implemented with the aim to assign in-depth examination in more targeted manner to patients at high risk of prostate cancer and to contribute to detection the cancer in the early stages.

Publisher

ECO-Vector LLC

Reference10 articles.

1. Surveillance, Epidemiology, and End Results Program. Prostate cancer. USA: National Cancer Institute. [cited 01 Jan 2023]. Available from: http://www.seer.cancer.gov

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Kaprin AD, Starinskii VV, Shakhzadova AO, editors. Malignant neoplasms in Russia in 2021 (morbidity and mortality). Moscow: P.A. Herzen MNIOI — branch of FGBU NMC Radiology of the Ministry of Health of Russia; 2022. (In Russ).

4. Kaprin AD, Starinskii VV, Shakhzadova AO, editors. State of oncological care for the Russian population in 2022. Moscow: P.A. Herzen MNIOI — branch of FGBU NMC Radiology of the Ministry of Health of Russia; 2023. (In Russ).

5. Clinical significance of PSA-associated tests in the diagnosis and staging of prostate cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3